Reconsidering the revised amyotrophic lateral sclerosis functional rating scale for ALS clinical trials

被引：4
|
作者：
de Jongh, Adriaan D. [1 ]
van den Berg, Leonard H. [1 ]
van Eijk, Ruben P. A. [1 ,2 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Neurol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands
[2] Julius Ctr Hlth Sci & Primary Care, Biostat & Res Support, Utrecht, Netherlands
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2021年 / 92卷 / 05期
关键词：
ALS; randomised trials; motor neuron disease;
D O I：
10.1136/jnnp-2020-325253
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：569 / 570
页数：2
相关论文
共 50 条
  • [41] ASSESSMENT OF COPING BEHAVIOR IN PATIENTS WITH ADVANCED AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) - APPLICABILITY OF A RATING-SCALE
    BOCKER, FM
    SEIBOLD, I
    PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, 1990, 40 (08) : 285 - 292
  • [42] Motor Deficit Evaluated by Timed Functional Measures Correlate with Functional Rating Scale Used in Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS), but Was in Discordance in Parkinson Disease (PD)
    Sanjak, Mohammed
    Mays, Jasmine
    Hirsch, Mark
    Englert, Danielle
    Iyer, Sanjay
    Conway, Jill
    Kaufman, Michael
    Bravver, Elena
    Brooks, Benjamin
    NEUROLOGY, 2013, 80
  • [43] Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design
    Fournier, Christina N.
    NEUROTHERAPEUTICS, 2022, 19 (04) : 1180 - 1192
  • [44] Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design
    Christina N. Fournier
    Neurotherapeutics, 2022, 19 : 1180 - 1192
  • [45] TEMPORAL DISTINCTION OF SPINAL AND BULBAR STAGES OF AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) - VALIDATION WITH TIME-TO-FAILURE ANALYSIS EMPLOYING ALS FUNCTIONAL RATING-SCALE
    BROOKS, BR
    SHODIS, KA
    SANJAK, M
    BELDEN, D
    ANNALS OF NEUROLOGY, 1995, 38 (02) : 294 - 294
  • [46] A Clinical Scale for Rating the Severity of Bulbar Lower Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis
    Zoccolella, Stefano
    Giugno, Alessia
    Milella, Giammarco
    Filardi, Marco
    Introna, Alessandro
    Fraddosio, Angela
    D'Errico, Eustachio
    Gnoni, Valentina
    Tamburrino, Ludovica
    Urso, Daniele
    Caputo, Francesca
    Misceo, Salvatore
    Logroscino, Giancarlo
    BIOMEDICINES, 2023, 11 (07)
  • [47] Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
    Goyal, Namita A.
    Berry, James D.
    Windebank, Anthony
    Staff, Nathan P.
    Maragakis, Nicholas J.
    van den Berg, Leonard H.
    Genge, Angela
    Miller, Robert
    Baloh, Robert H.
    Kern, Ralph
    Gothelf, Yael
    Lebovits, Chaim
    Cudkowicz, Merit
    MUSCLE & NERVE, 2020, 62 (02) : 156 - 166
  • [48] Sequential designs for clinical trials in amyotrophic lateral sclerosis
    Groeneveld, GJ
    van der Tweel, I
    Wokke, JHJ
    van den Berg, LH
    AMYOTROPHIC LATERAL SCLEROSIS, 2004, 5 (04): : 202 - 207
  • [49] Xaliproden in amyotrophic lateral sclerosis: early clinical trials
    Lacomblez, L
    Bensimon, G
    Douillet, P
    Doppler, V
    Salachas, F
    Meininger, V
    AMYOTROPHIC LATERAL SCLEROSIS, 2004, 5 (02): : 99 - 106
  • [50] POLIOVIRUS AND AMYOTROPHIC LATERAL SCLEROSIS (ALS)
    GANN, KL
    VIOLA, MV
    CLINICAL RESEARCH, 1978, 26 (04): : A626 - A626
12345